Side-by-side comparison of AI visibility scores, market position, and capabilities
$212.4B revenue 2025, 21.9% global share (+1.1pp), 57.3% US share, iPhone 16 best-selling Q1 2025, 232.1M units shipped 2024 (beat Samsung)
Apple iPhone is Apple's flagship smartphone line combining advanced mobile technology, premium design, and iOS software in devices that define the modern smartphone experience. The iPhone serves global consumers across all demographics with models ranging from budget-friendly SE versions to Pro Max devices featuring cutting-edge camera systems, processors, and display technology. Apple iPhone differentiates through seamless ecosystem integration, industry-leading privacy and security features, long-term software support, and consistent innovation in mobile photography, performance, and user experience.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.